1. Home
  2. PLUG vs SLNO Comparison

PLUG vs SLNO Comparison

Compare PLUG & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUG
  • SLNO
  • Stock Information
  • Founded
  • PLUG 1997
  • SLNO 1999
  • Country
  • PLUG United States
  • SLNO United States
  • Employees
  • PLUG N/A
  • SLNO N/A
  • Industry
  • PLUG Industrial Machinery/Components
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PLUG Energy
  • SLNO Health Care
  • Exchange
  • PLUG Nasdaq
  • SLNO Nasdaq
  • Market Cap
  • PLUG 1.6B
  • SLNO 3.8B
  • IPO Year
  • PLUG 1999
  • SLNO 2014
  • Fundamental
  • Price
  • PLUG $1.56
  • SLNO $82.45
  • Analyst Decision
  • PLUG Hold
  • SLNO Strong Buy
  • Analyst Count
  • PLUG 16
  • SLNO 9
  • Target Price
  • PLUG $1.76
  • SLNO $105.11
  • AVG Volume (30 Days)
  • PLUG 88.7M
  • SLNO 1.5M
  • Earning Date
  • PLUG 08-07-2025
  • SLNO 08-06-2025
  • Dividend Yield
  • PLUG N/A
  • SLNO N/A
  • EPS Growth
  • PLUG N/A
  • SLNO N/A
  • EPS
  • PLUG N/A
  • SLNO N/A
  • Revenue
  • PLUG $642,224,000.00
  • SLNO N/A
  • Revenue This Year
  • PLUG $18.11
  • SLNO N/A
  • Revenue Next Year
  • PLUG $25.29
  • SLNO N/A
  • P/E Ratio
  • PLUG N/A
  • SLNO N/A
  • Revenue Growth
  • PLUG N/A
  • SLNO N/A
  • 52 Week Low
  • PLUG $0.69
  • SLNO $41.50
  • 52 Week High
  • PLUG $3.34
  • SLNO $90.32
  • Technical
  • Relative Strength Index (RSI)
  • PLUG 62.03
  • SLNO 51.33
  • Support Level
  • PLUG $1.59
  • SLNO $79.70
  • Resistance Level
  • PLUG $1.85
  • SLNO $90.32
  • Average True Range (ATR)
  • PLUG 0.15
  • SLNO 3.66
  • MACD
  • PLUG 0.03
  • SLNO -0.41
  • Stochastic Oscillator
  • PLUG 68.34
  • SLNO 31.42

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: